Top Page
Eiken Chemical Co., Ltd.
(4549)
Eiken Chemical Co., Ltd. (4549) vs. iShares MSCI Japan ETF (EWJ)
Eiken Chemical Co., Ltd. Business Overview & Revenue Model
Eiken Chemical Co., Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.54B | 40.54B | 40.05B | 43.27B | 43.00B | 38.66B |
| Gross Profit | 16.51B | 16.51B | 16.72B | 20.51B | 20.57B | 18.53B |
| EBITDA | 5.56B | 5.56B | 5.84B | 9.73B | 10.55B | 8.58B |
| Net Income | 2.23B | 2.23B | 2.63B | 5.74B | 6.22B | 5.04B |
Balance Sheet | ||||||
| Total Assets | 62.37B | 62.37B | 61.65B | 66.28B | 62.51B | 55.69B |
| Cash, Cash Equivalents and Short-Term Investments | 9.87B | 9.87B | 16.31B | 18.32B | 16.12B | 9.23B |
| Total Debt | 4.47B | 4.47B | 4.33B | 4.31B | 4.19B | 1.16B |
| Total Liabilities | 18.77B | 18.77B | 15.68B | 16.74B | 16.71B | 14.02B |
| Stockholders Equity | 43.60B | 43.60B | 45.97B | 49.53B | 45.80B | 41.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 812.00M | 1.72B | 4.30B | 2.88B | 3.34B |
| Operating Cash Flow | 0.00 | 6.03B | 3.81B | 7.58B | 7.77B | 5.45B |
| Investing Cash Flow | 0.00 | -4.50B | -2.22B | -316.00M | -5.04B | -2.19B |
| Financing Cash Flow | 0.00 | -4.86B | -6.69B | -2.10B | 1.20B | -1.27B |
Eiken Chemical Co., Ltd. Technical Analysis
Eiken Chemical Co., Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | ¥77.32B | 35.23 | 2.14% | 3.80% | 6.68% | ||
51 Neutral | $7.81B | -0.22 | -40.01% | 2.29% | 21.48% | -2.11% | |
| ― | $303.09M | ― | -0.82% | ― | ― | ― | |
| ― | €757.13M | 10.60 | 8.31% | ― | ― | ― | |
79 Outperform | ¥32.75B | 10.71 | 2.43% | 7.99% | 28.81% | ||
74 Outperform | ¥16.87B | 16.18 | 3.43% | -8.07% | -38.21% | ||
73 Outperform | ¥273.87B | 20.01 | 1.87% | 4.43% | -1.39% |
Eiken Chemical Co., Ltd. Corporate Events
Eiken Chemical Co., Ltd. reported a positive financial performance for the three months ended June 30, 2025, with a 7.1% increase in net sales and significant growth in operating and ordinary profits compared to the previous year. The company’s improved financial results indicate a strong market position and potential for future growth, benefiting stakeholders and enhancing its industry standing.
Eiken Chemical Co., Ltd. has decided to transfer its equity interest in its subsidiary EIKEN CHINA CO., LTD. to improve production and management efficiency. The transfer will involve moving raw materials processing to its Nogi Factory and switching to direct sales, which is expected to enhance corporate value. The name of the transferee, a Chinese corporation, remains confidential, and the transfer is set to be completed by September 2025.
Eiken Chemical Co., Ltd. has completed the pay-in procedures for the disposal of treasury shares as restricted stock compensation, as resolved in a recent board meeting. This disposal involves a total of 118,009 common shares, distributed among company officers and employees, with a total value of approximately 251 million yen, potentially impacting the company’s financial structure and stakeholder interests.
Eiken Chemical Co., Ltd. has completed the acquisition of 60,400 of its own common shares for a total of 127,021,500 yen, as part of a broader initiative authorized by its Board of Directors to purchase up to 2,000,000 shares. This strategic move, executed through market purchases on the Tokyo Stock Exchange, is part of the company’s efforts to manage its capital structure and potentially enhance shareholder value.
Eiken Chemical Co., Ltd. has announced the disposal of treasury shares as part of a restricted stock compensation plan aimed at aligning the interests of its officers and employees with those of shareholders. This move is designed to motivate the company’s leadership and staff to focus on sustainable growth and enhance shareholder value over the medium to long term.
Eiken Chemical Co., Ltd. announced an amendment to its Articles of Incorporation, approved at the Ordinary General Meeting of Shareholders on June 24, 2025. The amendment involves changes to the method of deciding the disposal of surplus, specifically removing the requirement for a general meeting of shareholders to determine certain matters, allowing the Board of Directors to make these decisions, which could streamline the company’s decision-making process and potentially impact shareholder engagement.
Eiken Chemical Co., Ltd. has announced the progress of its treasury share acquisition, purchasing 237,400 common shares for approximately 499.97 million yen between May 1 and May 31, 2025. This move is part of a broader plan to acquire up to 2 million shares by July 31, 2025, which could impact the company’s market positioning and shareholder value.
Eiken Chemical Co., Ltd. has announced its opposition to a shareholder proposal from AVI Japan Opportunity Trust PLC, which includes amendments to the articles of incorporation and a buyback of shares. The company emphasizes its commitment to strengthening its governance structure with a board composed mainly of independent directors, aiming to enhance corporate value and shareholder value in the medium to long term. The board believes that maintaining decision-making authority on share buybacks and earnings appropriation within the board, rather than expanding shareholder rights, aligns with its strategic governance framework.
Eiken Chemical Co., Ltd. announced the retraction of a shareholder proposal by Dalton Kizuna Fund, a major shareholder. After evaluating six proposed director candidates, the company decided to nominate two candidates, Mr. Kinose and Mr. Toda, for its board. This decision aims to maintain board independence while enhancing corporate value, as both candidates have committed to acting independently of Dalton’s interests.
Eiken Chemical Co., Ltd. announced a resolution regarding the election of director candidates for its upcoming annual general shareholders’ meeting. The company plans to reappoint several directors and introduce new members to its board, which could influence its strategic direction and operational focus. This reshuffle may impact the company’s governance and potentially enhance its market position by bringing in fresh perspectives and expertise.
Eiken Chemical Co., Ltd. has announced a change in its shareholder return policy, aiming to increase the total return ratio to 50% or more, which includes dividends and repurchases of treasury stock. This shift reflects the company’s commitment to enhancing shareholder value and strengthening its financial position, with the new policy set to take effect from the fiscal year ending March 2026.
Eiken Chemical Co., Ltd. has announced upcoming changes in its executive leadership, effective after the 87th Ordinary General Meeting of Shareholders on June 24, 2025. These changes include the promotion of Yasuyoshi Mori to Director, Senior Vice President, and Executive Officer, and Michitoshi Doi to Vice President and Executive Officer, while several current executives will retire. The restructuring is expected to streamline operations and enhance the company’s strategic focus on research and development, production, and quality assurance.
Eiken Chemical Co., Ltd. has announced a new medium-term management plan for fiscal years 2025 to 2027, titled ‘Challenges to Innovation.’ This plan is intended to be a transformative period aimed at strengthening the company’s earnings base and advancing its long-term vision, EIKEN Vision 2030, by implementing fundamental changes.
Eiken Chemical Co., Ltd. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in net sales by 1.2% to ¥40,539 million. However, the company experienced declines in operating profit, ordinary profit, and profit attributable to owners of the parent, with decreases of 11.2%, 10.4%, and 15.4% respectively. Despite these declines, the company has forecasted a positive outlook for the fiscal year ending March 31, 2026, with expected increases in net sales and profits.
Eiken Chemical Co., Ltd. has decided to transfer its equity interests in its subsidiary, Eiken China, due to rising labor and transportation costs in Shanghai, which have impacted profitability. The transfer aims to enhance corporate value by improving production efficiency and management through concentrating raw material processing and converting sales to direct channels.
Eiken Chemical Co., Ltd. has announced its opposition to a shareholder proposal submitted by AVI Japan Opportunity Trust PLC, which will be presented at the upcoming Annual General Shareholders Meeting. The proposal includes amendments to the articles of incorporation and a buyback of shares. The company’s board believes that decisions regarding dividends should align with management strategies and be determined by the board to enhance corporate and shareholder value in the long term. Eiken Chemical has committed to a shareholder return policy with a target total return ratio of at least 50% from March 2026, emphasizing their focus on capital efficiency and shareholder profit.